Katherine Jane Pettinger

Katherine Jane Pettinger

Auto-generated profile, based on publicly available information

Katherine Jane Pettinger

Department of Health Sciences University of York York UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2014 in Gut
Verified
Journal Article
Open access
PDF file
SLSuling J Lin
Suling J Lin
JGJohann A Gagnon-Bartsch
Johann A Gagnon-Bartsch
ITIain Beehuat Tan
Iain Beehuat Tan
SESophie Earle
Sophie Earle
LRLouise Ruff
Louise Ruff
PTPatrick Tan
Patrick Tan
Objective: Differences in gastric cancer (GC) clinical outcomes between patients in Asian and non-Asian countries has been historically attributed to variability in clinical management. However, recent international Phase III trials suggest that even with standardised treatments, GC outcomes differ by geography. Here, we investigated gene expression differences between Asian and non-Asian GCs, and if these molecular differences might influence clinical outcome. Design: We compared gene expression profiles of 1016 GCs from six Asian and three non-Asian GC cohorts, using a two-stage meta-analysis design and a novel biostatistical method ( RUV-4 ) to adjust for technical variation between cohorts. We further validated our findings by computerised immunohistochemical analysis on two independent tissue microarray (TMA) cohorts from Asian and non-Asian localities (n=665). Results: Gene signatures differentially expressed between Asians and non-Asian GCs were related to immune function and inflammation. Non-Asian GCs were significantly enriched in signatures related to T-cell biology, including CTLA-4 signalling. Similarly, in the TMA cohorts, non-Asian GCs showed significantly higher expression of T-cell markers (CD3, CD45R0, CD8) and lower expression of the immunosuppressive T-regulatory cell marker FOXP3 compared to Asian GCs (p<0.05). Inflammatory cell markers CD66b and CD68 also exhibited significant cohort differences (p1600 GCs suggest that Asian and non-Asian GCs exhibit distinct tumour immunity signatures related to T-cell function. These differences may influence geographical differences in clinical outcome, and the design of future trials particularly in immuno-oncology.

1 February 2020 in eClinicalMedicine
Verified
Journal Article
Open access
KPKatherine J. Pettinger
Katherine J. Pettinger
KMKatie Mayers
Katie Mayers
LMLiz McKechnie
Liz McKechnie
BPBob Phillips
Bob Phillips
Determining which babies should receive antibiotics for potential early onset sepsis (EOS) is challenging. We performed a meta-analysis quantifying how many EOS cases might be 'missed' using the Kaiser Permanente electronic calculator, compared with National Institute for Health and Care Excellence (NICE) guidelines. A systematic literature search was carried out for studies citing the article in which the calculator was publicised. Studies were eligible if they presented data evaluating the calculator, either by retrospective case review or prospective cohort study. The primary outcome measure was numbers of culture positive EOS cases where the calculator did not recommend empirical antibiotics, but NICE guidelines would have. Data were pooled using a random effect meta-analysis. A subgroup analysis was performed using data from studies of babies exposed to chorioamnionitis. Eleven studies were included. There were a total of 75 EOS cases across the studies and a minimum of 14 (best case scenario), and a maximum of 22 (worst case scenario) cases where use of the calculator would have resulted in delayed or missed treatment, compared to if NICE guidelines had been followed. The probability of missed/delayed treatment for an EOS case were best case 0.19 [95% confidence intervals 0.11 - 0.29], worst case 0.31 [95% CI 0.17 - 0.49]. The probability of missing cases was significantly more in babies exposed to chorioamnionitis. A large proportion of EOS cases were 'missed' by the calculator. Further evaluation of the calculator is recommended before it is introduced into UK clinical practice. None.

13 August 2019 in Archives of Disease in Childhood
Verified
Journal Article
Open access
PDF file
KPKatherine J Pettinger
Katherine J Pettinger
BKBrian Kelly
Brian Kelly
TSTrevor A Sheldon
Trevor A Sheldon
MMMark Mon-Williams
Mark Mon-Williams
JWJohn Wright
John Wright
LHLiam J B Hill
Liam J B Hill
Objective To estimate the impact on early development of prematurity and summer birth and the potential ‘double disadvantage’ created by starting school a year earlier than anticipated during pregnancy, due to being born preterm. Design, setting and patients We investigated the impact of gestational and school-entry age on the likelihood of failing to achieve a ‘Good Level of Development’ (GLD) on the Early Years Foundation Stage Profile in 5-year-old children born moderate-to-late preterm using data from the Born in Bradford longitudinal birth cohort. We used hierarchical logistic regression to control for chronological maturity, and perinatal and socioeconomic factors. Results Gestational age and school-entry age were significant predictors of attaining a GLD in the 10 337 children who entered school in the correct academic year given their estimated date of delivery. The odds of not attaining a GLD increased by 1.09 (95% CI 1.06 to 1.11) for each successive week born early and by 1.17 for each month younger within the year group (95% CI 1.16 to 1.18). There was no interaction between these two effects. Children starting school a year earlier than anticipated during pregnancy were less likely to achieve a GLD compared with (1) other children born preterm (fully adjusted OR 5.51 (2.85–14.25)); (2) term summer births (3.02 (1.49–6.79)); and (3) preterm summer births who remained within their anticipated school-entry year (3.64 (1.27–11.48)). Conclusions These results confirm the developmental risks faced by children born moderate-to-late preterm, and—for the first time—illustrate the increased risk associated with ‘double disadvantage’.

10 November 2023 in Pediatrics
Verified
Journal Article
Open access
PDF file
KPKatherine J. Pettinger
Katherine J. Pettinger
CCClare Copper
Clare Copper
EBElaine Boyle
Elaine Boyle
SBSarah Blower
Sarah Blower
CHCatherine Hewitt
Catherine Hewitt
LFLorna Fraser
Lorna Fraser
CONTEXT: Very preterm birth (<32 weeks) is associated with increased risk of developmental disorders. Emerging evidence suggests children born 32 to 38 weeks might also be at risk. OBJECTIVES: To determine the relative risk and prevalence of being diagnosed with, or screening positive for, developmental disorders in children born moderately preterm, late preterm, and early term compared with term (≥37 weeks) or full term (39–40/41 weeks). DATA SOURCES: Medline, Embase, Psychinfo, Cumulative Index of Nursing, and Allied Health Literature. STUDY SELECTION: Reported ≥1 developmental disorder, provided estimates for children born 32 to 38 weeks. DATA EXTRACTION: A single reviewer extracted data; a 20% sample was second checked. Data were pooled using random-effects meta-analyses. RESULTS: Seventy six studies were included. Compared with term born children, there was increased risk of most developmental disorders, particularly in the moderately preterm group, but also in late preterm and early term groups: the relative risk of cerebral palsy was, for 32 to 33 weeks: 14.1 (95% confidence intervals [CI]: 12.3–16.0), 34 to 36 weeks: 3.52 (95% CI: 3.16–3.92) and 37 to 38 weeks: 1.44 (95% CI: 1.32–1.58). LIMITATIONS: Studies assessed children at different ages using varied criteria. The majority were from economically developed countries. All were published in English. Data were variably sparse; subgroup comparisons were sometimes based on single studies. CONCLUSIONS: Children born moderately preterm are at increased risk of being diagnosed with or screening positive for developmental disorders compared with term born children. This association is also demonstrated in late preterm and early term groups but effect sizes are smaller.

25 November 2017 in Archives of Disease in Childhood
Verified
Journal Article
Closed access
PDF file
KPKatherine J Pettinger
Katherine J Pettinger
LSLea Solman
Lea Solman
BMBipin Mathew
Bipin Mathew
GTGayle Taylor
Gayle Taylor
SCSheila Clark
Sheila Clark
SPSusan Picton
Susan Picton
A newborn boy presented at birth with a firm erythematous nodule, measuring 25×18 mm on the medial aspect of his left shin below the knee (figure 1). The lesion had a depressed centre covered with a crust and subtle telangiectasia on the edges. The rest of the examination was normal. He had been born at term following an uncomplicated pregnancy. Figure 1 Erythematous nodule measuring 25×18 mm on the medial aspect left shin. A 4 mm punch biopsy of the lesion was performed, revealing S100 …

21 July 2018 in Archives of Disease in Childhood - Education & Practice Edition
Verified
Journal Article
Closed access
PDF file
KPKatherine J Pettinger
Katherine J Pettinger
LMLucy McKelvie
Lucy McKelvie
KJKathryn Johnson
Kathryn Johnson
ABAndrew Breeze
Andrew Breeze
IBIan Berry
Ian Berry
JCJennifer Campbell
Jennifer Campbell
A baby girl was born overnight at 27 weeks’ gestation following spontaneous labour, weighing 940 g. She was the second child of healthy non-consanguineous parents. The fetal medicine team were involved. The 20-week ultrasound findings were: At birth, the baby had no respiratory effort, but responded well to bag mask inflation breaths. Clinical examination revealed (see figure 1): Figure 1 Photograph of the infant in her incubator, demonstrating bilateral talipes, clenched hands and clinodactyly, smooth philtrum and microstomia with fixed jaw. Her oxygen requirement increased to 100%, despite high-flow nasal …